7Baggers
 Nuvalent stock price target raised to $155 from $125 at Guggenheim  Investing.com India Tue, 18 Nov 2025 12:24:59 GMT
 Nuvalent price target raised to $155 from $125 at Guggenheim  TipRanks Tue, 18 Nov 2025 12:23:13 GMT
 Nuvalent rises on positive neladalkib trial findings  The Pharma Letter Tue, 18 Nov 2025 12:18:53 GMT
 Nuvalent aiming for approval on pivotal trial data for NSCLC candidate  Yahoo Finance Tue, 18 Nov 2025 11:24:15 GMT
 Nuvalent’s Surge: What’s Behind the Buzz?  StocksToTrade Tue, 18 Nov 2025 02:04:00 GMT
 Why Did Nuvalent Stock Surge 15% Today?  Stocktwits Tue, 18 Nov 2025 00:34:08 GMT
 Nuvalent Sees Opportunity For Neladalkib To Unseat ALK Rivals  Citeline News & Insights Mon, 17 Nov 2025 22:47:41 GMT
 Nuvalent announces $500 million public offering of common stock  Investing.com Mon, 17 Nov 2025 22:42:57 GMT
 Why This Hot Biotech Just Surged Past A Profit-Taking Zone  Investor's Business Daily Mon, 17 Nov 2025 21:40:00 GMT
 Nuvalent announces $500M Class A common stock offering  TipRanks Mon, 17 Nov 2025 21:29:16 GMT
 Nuvalent Announces Public Offering of Common Stock  Morningstar Mon, 17 Nov 2025 21:01:00 GMT
 Growth or Bubble? Nuvalent’s Rise Examined  timothysykes.com Mon, 17 Nov 2025 19:33:00 GMT
 Nuvalent price target raised to $152 from $112 at Barclays  TipRanks Mon, 17 Nov 2025 18:50:17 GMT
 Nuvalent lung cancer readout sets up possible duel with Pfizer's Lorbrena  FirstWord Pharma Mon, 17 Nov 2025 18:28:43 GMT
 why did nuvalent stock surge 15% today?  Stocktwits Mon, 17 Nov 2025 17:54:00 GMT
 Nuvalent price target raised to $135 from $115 at Stifel  TipRanks Mon, 17 Nov 2025 17:50:20 GMT
 Nuvalent price target raised to $149 from $140 at Leerink  TipRanks Mon, 17 Nov 2025 16:35:50 GMT
 Nuvalent’s Stock Soars with Precision Oncology Promise  timothysykes.com Mon, 17 Nov 2025 16:33:00 GMT
 Nuvalent presses ahead in ALK | ApexOnco - Clinical Trials news and analysis  Oncology Pipeline Mon, 17 Nov 2025 15:23:06 GMT
 Transcript : Nuvalent, Inc. - Special Call  MarketScreener Mon, 17 Nov 2025 15:20:54 GMT
 nuvalent stock hits 52-week high at $104.99  Investing.com India Mon, 17 Nov 2025 15:20:15 GMT
 European firms raise two big funds for early biotech  statnews.com Mon, 17 Nov 2025 14:40:13 GMT
 Nuvalent stock falls after pivotal lung cancer drug data release  Investing.com Mon, 17 Nov 2025 14:28:00 GMT
 Nuvalent announces topline data from ALKOVE-1 trial  TipRanks Mon, 17 Nov 2025 12:46:28 GMT
 nuvalent reports positive data for lung cancer drug neladalkib  Investing.com India Mon, 17 Nov 2025 12:20:47 GMT
 Nuvalent’s Stock Soars on Promising Trial Data  TipRanks Mon, 17 Nov 2025 12:04:34 GMT
 Nuvalent Announces Positive Data for ALKOVE-1 Trial  TipRanks Mon, 17 Nov 2025 12:01:31 GMT
 highly rated biotech unveils new promise in lung cancer  Investor's Business Daily Mon, 17 Nov 2025 11:30:00 GMT
 Repare +30%, Nuvalent +9% Lead After-Hours Biotech Gains  Nasdaq Mon, 17 Nov 2025 04:41:00 GMT
 Nuvalent (NUVL): Assessing Valuation After Recent Share Price Gains  simplywall.st Sun, 16 Nov 2025 01:02:31 GMT
 Nuvalent to share pivotal data for ALK inhibitor in lung cancer  Investing.com Fri, 14 Nov 2025 21:25:48 GMT
 Canaccord starts ‘best-in-class’ Nuvalent with Buy rating  TipRanks Wed, 12 Nov 2025 13:53:08 GMT
 Canaccord Genuity Initiates Coverage on Nuvalent (NUVL) with "Bu  GuruFocus Wed, 12 Nov 2025 12:43:51 GMT
 Nuvalent Shows Market Leadership With Jump To 83 RS Rating  Investor's Business Daily Wed, 12 Nov 2025 08:00:00 GMT
 stocks with rising relative price strength: nuvalent  MSN Sat, 08 Nov 2025 16:39:28 GMT
 Stocks With Rising Relative Price Strength: Nuvalent  Investor's Business Daily Fri, 07 Nov 2025 08:00:00 GMT
 nuvalent: interesting product, but aggressive valuation (nasdaq:nuvl)  Seeking Alpha Wed, 05 Nov 2025 02:28:01 GMT
 nuvalent unveils patient outcomes data at key cancer conference  Traders Union Tue, 04 Nov 2025 22:45:46 GMT
 published on: 2025-11-04 11:51:01  newser.com Tue, 04 Nov 2025 17:51:01 GMT
 Nuvalent: Interesting Product, But Aggressive Valuation (NASDAQ:NUVL)  Seeking Alpha Tue, 04 Nov 2025 08:00:00 GMT
 published on: 2025-11-02 23:09:14  newser.com Mon, 03 Nov 2025 06:36:58 GMT

Nuvalent, Inc.
(NASDAQ:NUVL) 

NUVL stock logo

Nuvalent, Inc., a preclinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor, designed to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant muta...

Founded: 2017
CEO: James Porter  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends